Targeting the IL-6/JAK/STAT3 signalling axis in cancer

DE Johnson, RA O'Keefe, JR Grandis - Nature reviews Clinical …, 2018 - nature.com
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …

Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy

K Mortezaee, J Majidpoor - Cellular Oncology, 2022 - Springer
Macrophages are the most abundant and one of the most critical cells of tumor immunity.
They provide a bridge between innate and adaptive immunity through releasing cytokines …

Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial …

E Thomas, RS Thankan… - Molecular …, 2022 - Wiley Online Library
Cancer stem cells (CSCs) virtually present in all tumors albeit in small numbers are primarily
responsible for driving cancer progression, metastasis, drug resistance, and recurrence …

COVID-19–Induced modifications in the tumor microenvironment: do they affect cancer reawakening and metastatic relapse?

F Francescangeli, ML De Angelis, M Baiocchi… - Frontiers in …, 2020 - frontiersin.org
Severe coronavirus disease 2019 (COVID-19) causes an uncontrolled activation of the
innate immune response, resulting in acute respiratory distress syndrome and systemic …

[HTML][HTML] Association between interleukin-6 and head and neck squamous cell carcinoma: A systematic review

U Uz, G Eskiizmir - Clinical and experimental …, 2021 - synapse.koreamed.org
Abstract Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in
several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have …

Invasion-related factors as potential diagnostic and therapeutic targets in oral squamous cell carcinoma—a review

SBSM Siriwardena, T Tsunematsu, G Qi… - International journal of …, 2018 - mdpi.com
It is well recognized that the presence of cervical lymph node metastasis is the most
important prognostic factor in oral squamous cell carcinoma (OSCC). In solid epithelial …

[HTML][HTML] Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting

Q Guo, Y Zhou, T Xie, Y Yuan, H Li, W Shi, L Zheng… - Genes & …, 2024 - Elsevier
There are few tumor cell subpopulations with stem cell characteristics in tumor tissue,
defined as cancer stem cells (CSCs) or cancer stem-like cells (CSLCs), which can …

IL-6 in the ecosystem of head and neck cancer: possible therapeutic perspectives

M Španko, K Strnadová, AJ Pavlíček, P Szabo… - International Journal of …, 2021 - mdpi.com
Interleukin-6 (IL-6) is a highly potent cytokine involved in multiple biological processes. It
was previously reported to play a distinct role in inflammation, autoimmune and psychiatric …

5T4-targeted therapy ablates cancer stem cells and prevents recurrence of head and neck squamous cell carcinoma

SA Kerk, KA Finkel, AT Pearson, KA Warner… - Clinical Cancer …, 2017 - AACR
Purpose: Locoregional recurrence is a frequent treatment outcome for patients with
advanced head and neck squamous cell carcinoma (HNSCC). Emerging evidence suggests …

A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment

F Nazari, AT Pearson, JE Nör… - PLoS computational …, 2018 - journals.plos.org
Targeting key regulators of the cancer stem cell phenotype to overcome their critical
influence on tumor growth is a promising new strategy for cancer treatment. Here we present …